Article(electronic)#1November 2014
The in vivo genotoxicity studies on nivalenol and deoxynivalenol
In: EFSA supporting publications, Volume 11, Issue 11
ISSN: 2397-8325
Search results
Filter
2 results
Sort by:
Checking availability at your location
This article is also available at your library: |
electronic
print
Open Access#22020
Risk Governance of Emerging Technologies Demonstrated in Terms of its Applicability to Nanomaterials
Isigonis, P; Afantitis, A; Antunes, D; Bartonova, A; Beitollahi, A; Bohmer, N; Bouman, E; Chaudhry, Q
Isigonis, P; Afantitis, A; Antunes, D; Bartonova, A; Beitollahi, A; Bohmer, N; Bouman, E; Chaudhry, Q; Cimpan, M. R; Cimpan, E; Doak, S; Dupin, D; Fedrigo, D; Fessard, V; Gromelski, M; Gutleb, A. C; Halappanavar, S; Hoet, P; Jeliazkova, N; Jomini, S; Lindner, S; Linkov, I; Longhin, E. M; Lynch, I; Malsch, I; Marcomini, A; Mariussen, E; de la Fuente, J. M; Melagraki, G; Murphy, F; Neaves, M; Packroff, R; Pfuhler, S; Puzyn, T; Rahman, Q; Pran, E. R; Semenzin, E; Serchi, T; Steinbach, C; Trump, B; Vrcek, I. V; Warheit, D; Wiesner, M. R; Willighagen, E; Dusinska, M
Nanotechnologies have reached maturity and market penetration that require nano-specific changes in legislation and harmonization among legislation domains, such as the amendments to REACH for nanomaterials (NMs) which came into force in 2020. Thus, an assessment of the components and regulatory boundaries of NMs risk governance is timely, alongside related methods and tools, as part of the global efforts to optimise nanosafety and integrate it into product design processes, via Safe(r)-by-Design (SbD) concepts. This paper provides an overview of the state-of-the-art regarding risk governance of NMs and lays out the theoretical basis for the development and implementation of an effective, trustworthy and transparent risk governance framework for NMs. The proposed framework enables continuous integration of the evolving state of the science, leverages best practice from contiguous disciplines and facilitates responsive re-thinking of nanosafety governance to meet future needs. To achieve and operationalise such framework, a science-based Risk Governance Council (RGC) for NMs is being developed. The framework will provide a toolkit for independent NMs' risk governance and integrates needs and views of stakeholders. An extension of this framework to relevant advanced materials and emerging technologies is also envisaged, in view of future foundations of risk research in Europe and globally.
BASE